Esperion Therapeutics CEO Sheldon Koenig's 2022 pay falls 51% to $3.8M
Esperion Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 13, 2023
Esperion Therapeutics reported fiscal year 2022 executive compensation information on April 13, 2023.
In 2022, three executives at Esperion Therapeutics received on average a compensation package of $2.2M, a 57% decrease compared to previous year.
Average pay of disclosed executives at Esperion Therapeutics
Sheldon L. Koenig, Chief Executive Officer, received $3.8M in total, which decreased by 51% compared to 2021. 54% of Koenig's compensation, or $2.1M, was in option awards. Koenig also received $501K in non-equity incentive plan, $683K in salary, $550K in stock awards, as well as $14K in other compensation.
JoAnne Foody, Chief Medical Officer, received a compensation package of $1.5M, which decreased by 58% compared to previous year. 41% of the compensation package, or $627K, was in option awards.
Benjamin Looker, General Counsel, earned $1.3M in 2022.
Related executives
You may also like
Source: SEC filing on April 13, 2023.